Search Results - "Pourcher, E"

RLS patients can also develop compulsions on dopaminergic agonists by Pourcher, E, Bond, L

“…Introduction The aim of this study was to assess the frequency of self-reported compulsive behaviours, depressive and stress symptoms and sleep disorders in a…”
Get full text

Dopaminergic innervation of the human subventricular zone: a comparison between Huntington's chorea and Parkinson's disease by Parent, Martin, Bédard, C, Pourcher, E

“…The subventricular zone retains its neurogenic capacity throughout life and, as such, is often considered a potential source for endogenous repair in…”
Get full text

P2.114 The effect of levodopa and mixed noradrenergic/dopaminergic medication on freezing of gait in Parkinson's disease by Pourcher, E, Diallo, B

Get full text

P2.101 Efflcacy and safety of preladenant, a novel A2A receptor antagonist, as a levodopa adjunct in patients with moderate-to-severe Parkinson's disease by Hauser, R.A, Pourcher, E, Micheli, F, Mok, V, Onofrj, M, Huyck, S.B, Wolski, K.P, Cantillon, M

Get full text

Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial by LeWitt, Peter A, Hauser, Robert A, Pahwa, Rajesh, Isaacson, Stuart H, Fernandez, Hubert H, Lew, Mark, Saint-Hilaire, Marie, Pourcher, Emmanuelle, Lopez-Manzanares, Lydia, Waters, Cheryl, Rudzínska, Monika, Sedkov, Alexander, Batycky, Richard, Oh, Charles

“…Patients with Parkinson's disease chronically treated with levodopa commonly have delayed or unpredictable onset of its benefits after oral intake. In this…”
Get full text

Comparison of two dosages of tolcapone added to levodopa in nonfluctuating patients with PD by SUCHOWERSKY, Oksana, BAILEY, Peter, POURCHER, E, BULGER, Lynne, FACCIPONTE, Giovanni

“…The efficacy and safety of two dosages of tolcapone were compared in a 12-week crossover trial involving 118 nonfluctuating patients with PD on a stable dose…”
Get full text

Neuroleptic associated tardive dyskinesias in young people with psychoses by Pourcher, E, Baruch, P, Bouchard, R H, Filteau, M J, Bergeron, D

“…Apart from ageing, the factors associated with vulnerability to the emergence of tardive dyskinesia are poorly defined. Risk factors associated with the…”
Get more information

Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: A 12-week, double-blind, randomized, parallel-group, placebo-controlled study by Walters, Arthur S., Ondo, William G., Dreykluft, Tilman, Grunstein, Ron, Lee, Daniel, Sethi, Kapil

“…Restless legs syndrome (RLS) is a neurological condition with significant impact on sleep and quality of life (QoL). This double‐blind, randomized, 12‐week,…”
Get full text

Efficacy of the combination of buspirone and carbamazepine in early posttraumatic delirium by Pourcher, E, Filteau, M J, Bouchard, R H, Baruch, P

Get more information

Ethosuximide and tremor in Parkinson's disease: a pilot study by Pourcher, E, Gomez-Mancilla, B, Bédard, P J

“…Following the demonstration of an anti-tremor effect of ethosuximide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) monkey model, we have tested…”
Get more information

Organic brain dysfunction and cognitive deficits in young schizophrenic patients with tardive dyskinesia by Pourcher, E, Cohen, H, Cohen, D, Baruch, P, Bouchard, R H

“…Tardive dyskinesia (TD) has been associated with cognitive deficits, especially in older psychiatric patients on neuroleptic medication. This study…”
Get more information

The effect of neuroleptic treatments on executive function and symptomatology in schizophrenia: A 1-year follow up study by Rémillard, Sophie, Pourcher, Emmanuelle, Cohen, Henri

“…Cognitive dysfunctions (as in memory, attention and executive function) have been recognized as fundamental features of schizophrenia. Executive dysfunction is…”
Get full text

Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's disease by Temlett, J A, Quinn, N P, Jenner, P G, Marsden, C D, Pourcher, E, Bonnet, A M, Agid, Y, Markstein, R, Lataste, X

“…The effect of stimulation of cerebral dopamine D-1 receptors by CY 208-243 on motor disability was tested in MPTP-treated parkinsonian marmosets and patients…”
Get more information

Acoustical analysis of vowel production in people with Parkinson’s disease by Richard, Gabrielle, Menard, Lucie, Cohen, Henri, Pourcher, Emmanuelle

“…Speech is the sound wave produced by the vibration of the vocal chords finely tuned by the supraglottal articulators: the tongue, the lips, and the jaw…”
Get full text

The dimensional approach to clinical psychopharmacology: a polysemous concept by Baruch, P, Filteau, M J, Bouchard, R H, Pourcher, E, Vincent, P, Jouvent, R

“…The last decade has seen significant progress in the development and specific clinical application of selective psychotropes. The dimensional approach to…”
Get full text

A dissociation between real and simulated movements in Parkinsonʼs disease by Frak, Victor, Cohen, Henri, Pourcher, Emmanuelle

“…Subcortical lesions have been simultaneously implicated in both real and simulated movement deficits. However, the analysis of the simulated opposition axis in…”
Get full text

Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease by GUTTMAN, M

Get full text

P2.101 Efflcacy and safety of preladenant, a novel A 2A receptor antagonist, as a levodopa adjunct in patients with moderate-to-severe Parkinson's disease by Hauser, R.A., Pourcher, E., Micheli, F., Mok, V., Onofrj, M., Huyck, S.B., Wolski, K.P., Cantillon, M.

Get full text

Evaluation of the EMIT Tox enzyme immunoassay for toxicological analysis of benzodiazepines in serum by Pegon, Y, Pourcher, E, Vallon, J J

“…Immunoenzymatic test, EMIT Tox, proposed for qualitative and semi quantitative determination of toxicological levels of benzodiazepines in serum is compared…”
Get more information

P102 A long-term study on the safety of rivastigmine capsule and patch in mild to moderate Parkinson’s disease dementia by Storch, A., Barone, P., De Deyn, P., Emre, M., Kulisevsky, J., Poewe, W., Pourcher, E., van Laar, T., Tenenbaum, N., Tekin, S.

Get full text